ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm – BCLI

<p>NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) &#8212; WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/rosen-trusted-investor-counsel-encourages-brainstorm-cell-therapeutics-inc-investors-with-losses-to-secure-counsel-before-important-january-2-deadline-in-securities-class-action-first-filed-by-the/">ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm – BCLI</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>